Effect of prior morphine-3-glucuronide exposure on morphine disposition and antinociception (Q73595593)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9260872%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Effect of prior morphine-3-glucuronide exposure on morphine disposition and antinociception (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9260872%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

D M Ouellet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9260872%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

G M Pollack

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9260872%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 May 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9260872%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9260872%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9260872%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9260872%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

1451-1457

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9260872%20AND%20SRC:MED&resulttype=core&format=json

High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Morphine metabolism in cancer patients on increasing oral doses--no evidence for autoinduction or dose-dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Biochemical basis for analgesic activity of morphine-6-glucuronide. I. Penetration of morphine-6-glucuronide in the brain of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Potential analgesic contribution from morphine-6-glucuronide in CSF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Morphine-6-glucuronide, a potent mu agonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinociceptive effect of morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Morphine-3-glucuronide--a potent antagonist of morphine analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

A pharmacokinetic-pharmacodynamic model of tolerance to morphine analgesia during infusion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Species difference of site-selective glucuronidation of morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Differential inhibition of hepatic morphine UDP-glucuronosyltransferases by metal ions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Lack of effect of morphine-3-glucuronide on the spinal antinociceptive actions of morphine in the rat: an electrophysiological study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Morphine-3-glucuronide: silent regulator of morphine actions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Morphine-3-glucuronide: evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Enterohepatic recirculation and renal metabolism of morphine in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

Acute tolerance in morphine analgesia: continuous infusion and single injection in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900086-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(97)00086-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9260872%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference